Brief: Scynexis Q3 Pretax Profit USD -8.591 Million
05/11/2025 21:20
Nov 05 (Reuters) - Scynexis Q3 product revenue USD 334 thousand. Q3 operating expenses USD 8.739 million Q3 basic EPS USD -0.17 Q3 net income USD -8.591 million
Recent news on Scynexis
See all newsBrief: Scynexis Announces Phase 1 Study Results For Scy-770, A Novel, Highly Selective, Oral Direct Ampk Activator For The Treatment Of Autosomal Dominant Polycystic Kidney Disease
Brief: Scynexis Announces Appointment Of Sanjay Subramanian As Chief Financial Officer
Scynexis Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Scynexis Q2 swings to profit on warrant adjustment; advances drug studies
Scynexis Inc Expected To Post A Loss Of 51 Cents A Share: Earnings Preview